GLP-2TZ 10mg
GLP-2TZ 10mg is a synthetic research peptide designed for laboratory investigation of dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor signaling, incretin biology, metabolic signaling, and related cellular pathways.
GLP-2TZ corresponds to the research compound tirzepatide, a modified peptide extensively studied for its activity at both the GIP receptor (GIPR) and GLP-1 receptor (GLP-1R). This dual-receptor profile has made the compound an important research tool for investigating interactions between two major components of the incretin signaling system.
GLP-2TZ 10mg is supplied strictly for laboratory research and analytical investigation. It is not intended for human or animal consumption, clinical use, diagnostic use, therapeutic use, or veterinary use.
Research Specifications
|
|
| Product Name |
GLP-2TZ |
| Vial Quantity |
10mg |
| Form |
Lyophilized Powder |
| Research Classification |
Dual GIP/GLP-1 Receptor Agonist Research Peptide |
| Primary Research Targets |
GIP Receptor (GIPR) & GLP-1 Receptor (GLP-1R) |
| Research Pathways |
Incretin & Metabolic Signaling |
| Peptide Length |
39 Amino Acids |
| Molecular Formula |
C₂₂₅H₃₄₈N₄₈O₆₈ |
| Molecular Weight |
Approximately 4,813 g/mol |
| Research Identity |
Tirzepatide |
| CAS Number |
2023788-19-2 |
| Intended Use |
Laboratory Research Only |
Dual GIP & GLP-1 Receptor Research
GLP-2TZ is studied in relation to two major incretin receptors: the GIP receptor (GIPR) and the GLP-1 receptor (GLP-1R).
Both receptors belong to the G-protein-coupled receptor family and participate in cellular signaling associated with nutrient-responsive endocrine and metabolic processes.
The ability to investigate activity across both receptor systems distinguishes dual GIP/GLP-1 receptor agonists from compounds designed primarily around GLP-1 receptor activity alone.
This dual-receptor profile provides researchers with a model for studying how simultaneous activation of two incretin-related signaling pathways may influence downstream cellular responses.
Incretin Signaling Research
The incretin system represents an important area of metabolic research.
GIP and GLP-1 are naturally occurring peptide hormones involved in physiological responses to nutrient exposure. Their respective receptors initiate intracellular signaling cascades that have been studied extensively in relation to pancreatic endocrine activity and broader metabolic regulation.
Research involving tirzepatide and related dual-receptor agonists has expanded scientific investigation into how GIPR and GLP-1R signaling may interact within the same experimental system.
These compounds therefore provide researchers with tools for investigating incretin receptor biology beyond single-receptor models.
GIP Receptor Research
The glucose-dependent insulinotropic polypeptide receptor, or GIPR, is a G-protein-coupled receptor activated physiologically by GIP.
GIPR signaling has been investigated across multiple experimental systems involving endocrine and metabolic biology. Activation of the receptor initiates intracellular signaling pathways that include cyclic adenosine monophosphate (cAMP) and associated downstream mechanisms.
GLP-2TZ provides a research model for investigating GIP receptor signaling as one component of a dual incretin-receptor system.
GLP-1 Receptor Research
The GLP-1 receptor is another G-protein-coupled receptor central to incretin research.
GLP-1R activation has been studied extensively in experimental models involving pancreatic endocrine signaling, gastrointestinal biology, central signaling pathways, and metabolic regulation.
By combining GLP-1R activity with GIPR activity within the same molecule, GLP-2TZ allows researchers to investigate signaling characteristics that differ from those of selective GLP-1 receptor agonists.
Metabolic Signaling Research
Dual incretin-receptor research has become an important area for understanding the molecular relationships among nutrient sensing, endocrine communication, receptor activation, and cellular metabolic signaling.
GIPR and GLP-1R signaling can influence overlapping as well as distinct intracellular pathways. Investigating these receptors simultaneously provides researchers with a framework for examining receptor interactions and downstream signaling responses under controlled experimental conditions.
Research involving these pathways remains experimental and should not be interpreted as establishing therapeutic effects for research materials.
Molecular Research Profile
GLP-2TZ corresponds to tirzepatide, a 39-amino-acid synthetic peptide engineered for activity at both GIP and GLP-1 receptors.
Its molecular formula is:
C₂₂₅H₃₄₈N₄₈O₆₈
with a molecular weight of approximately:
4,813 g/mol
Tirzepatide incorporates structural modifications that distinguish it from naturally occurring incretin peptides, including conjugation to a C20 fatty diacid moiety through a molecular linker.
These structural characteristics have made the molecule useful for research examining relationships among peptide engineering, receptor activity, molecular stability, and duration of biological signaling.
The CAS Registry Number associated with tirzepatide is 2023788-19-2.
Dual-Receptor Agonist Research
Synthetic dual-receptor agonists represent an important area of peptide research because a single engineered molecule can be used to investigate signaling across multiple receptor systems.
Research involving tirzepatide has contributed substantially to scientific understanding of combined GIPR and GLP-1R activation, providing a framework for comparing dual-receptor signaling with selective GLP-1 receptor agonism.
GLP-2TZ provides research material for continued laboratory investigation of these pathways and the broader molecular biology associated with incretin receptor signaling.
Lyophilized Research Peptide
GLP-2TZ 10mg is supplied in lyophilized powder form for laboratory research.
Lyophilization removes water from the material under controlled conditions, producing a stable dry research format suitable for storage and subsequent laboratory preparation according to established research protocols.
Batch-specific analytical documentation may be available to provide additional information regarding the identity and purity of the research material.
Research Use Only
GLP-2TZ 10mg is intended strictly for laboratory research purposes only.
This product is not intended for human consumption, animal consumption, clinical use, diagnostic use, therapeutic use, veterinary use, or for the treatment, cure, mitigation, or prevention of any disease.
